Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FULC
FULC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FULC News
Fulcrum Therapeutics Grants Stock Options to New Employee
Feb 06 2026
Newsfilter
BMO Initiates Medline Coverage with $45 Price Target
Jan 12 2026
Benzinga
Fulcrum Grants 30,400 Stock Options to New Employees at $10.84 Exercise Price
Jan 09 2026
Globenewswire
Fulcrum Therapeutics Launches $150 Million Public Offering to Fund R&D
Dec 08 2025
Globenewswire
Fulcrum Therapeutics Shares Surge Following Encouraging Sickle Cell Study Results
Dec 08 2025
Benzinga
Monday's Top Sectors: Computer Peripherals and Pharmaceuticals
Dec 08 2025
NASDAQ.COM
Crude Oil Declines by More Than 1%; Structure Therapeutics Stock Soars
Dec 08 2025
Benzinga
Major Stocks on the Rise Monday: Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana, and More
Dec 08 2025
Benzinga
Confluent Shares Surge Nearly 32%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 08 2025
Benzinga
Fulcrum Therapeutics Stock Increases Following Encouraging Phase 1b Sickle Cell Trial Outcomes
Dec 08 2025
SeekingAlpha
Fulcrum Reports Positive 20 mg Dose Trial Results with 9.9% HbF Increase
Dec 06 2025
Globenewswire
Fulcrum Reports Significant HbF Increases in 20 mg Dose Trial Results
Dec 06 2025
Newsfilter
Fulcrum Grants 5,250 Stock Options to New Employee at $9.87 Exercise Price
Dec 05 2025
Globenewswire
Fulcrum to Showcase New Data from PIONEER Trial on Sickle Cell Disease
Dec 03 2025
NASDAQ.COM
Major Stocks Including Helmerich and Payne, Invivyd, and Home Depot Decline in Tuesday's Pre-Market Trading
Nov 18 2025
Benzinga
Gorilla Technology Shares Rise Approximately 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Nov 18 2025
Benzinga
Show More News
